Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	107.88B
Revenue (ttm)	32.16B
Net Income (ttm)	647.72M
Shares Out	8.41M
EPS (ttm)	75.61
PE Ratio	169.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,045
Average Volume	57,088
Open	12,750
Previous Close	12,690
Day's Range	12,580 - 12,940
52-Week Range	11,960 - 21,500
Beta	1.05
RSI	48.67
Earnings Date	Mar 16, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.